FDA Weighs Wellness Peptides
2:14–3:07 · 53s
A federal advisory panel debates lifting restrictions on unapproved peptides touted for longevity and recovery despite scant human data.
2:14–3:07 · 53s
A federal advisory panel debates lifting restrictions on unapproved peptides touted for longevity and recovery despite scant human data.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.